🔗 Visit the ClinicalTrials.gov page for NCT02101216
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. | Clin Ther | 2001 | 1.93 |
| 2 | Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS. | J Biol Chem | 2005 | 1.24 |
| 3 | Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors. | Curr Pharm Des | 2004 | 0.98 |
| 4 | Abacavir. | Drugs | 1998 | 0.95 |
| 5 | The cost of psoriasis treatment. | J Eur Acad Dermatol Venereol | 2001 | 0.77 |
| 6 | From conventional to cutting edge: the new era of biologics in treatment of psoriasis. | Dermatol Ther | 2008 | 0.77 |